Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9701736
APP PUB NO 20150030607A1
SERIAL NO

14511013

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are neutralizing antibodies with cross-neutralizing activity and cross-protective effects against divergent stains of influenza virus, which are specific for an epitope having at least 90% homology to amino acids +72-115 of the HA1 domain of H5N1 influenza virus hemagglutinin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEW YORK BLOOD CENTER INC310 EAST 67TH STREET NEW YORK NY 10065

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Du, Lanying Rego Park, US 12 67
Jiang, Shibo New York, US 38 308
Zhou, Yusen Beijing, CN 5 67

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 11, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 11, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00